| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |